Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.84 USD | +5.38% | +6.67% | +33.33% |
07/05 | Cogent Biosciences Q1 Loss Widens | MT |
07/05 | Cogent Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+33.33% | 750M | |
+9.58% | 115B | |
+12.41% | 107B | |
-2.59% | 21.6B | |
-12.38% | 22.31B | |
-5.29% | 19.19B | |
-3.35% | 18.23B | |
-38.57% | 17.62B | |
+7.51% | 14.26B | |
+35.67% | 12.37B |
- Stock Market
- Equities
- COGT Stock
- News Cogent Biosciences, Inc.
- Wedbush Trims Cogent Biosciences' Price Target to $19 From $20, Keeps Outperform Rating